semaglutide / tirzepatide Maintenance therapy on or Tirzepatide vs. Ozempic: Comparing Diabetes

Reliability and validity of a macronutrient self-selection paradigm and a food preference questionnaire

We support both insured patients and patients looking for self-pay compounded tirzepatide options

April 1, 2024: Ozempic Manufacturer Novo Nordisk Sues Pharmacies for Knock-Offs Ozempic manufacturer Novo Nordisk continues to pursue lawsuits against pharmacies that sell compounded semaglutide

How Tirzepatide Works For Weight Loss Tirzepatide works through a dual-agonist design, targeting GLP-1 and GIP receptors

This group often sees a faster percentage-based transformation because starting weights are lower

Gastrointestinal side effects may lead to treatment discontinuation in some patients, though severe cases remain rare and can be mitigated with appropriate monitoring (62)